Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Immunome Inc.Listing on record | Award | — | SEC | |
Immunome Inc.Listing on record | AwardD (derivative) | $185.9K | SEC | |
Immunome Inc.Listing on record | AwardD (derivative) | — | SEC | |
NeuBase Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Immunome Inc.Listing on record | AwardD (derivative) | — | SEC | |
Lantern Pharma Inc.Listing on record | AwardD (derivative) | — | SEC | |
NeuBase Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Immunome Inc.Listing on record | AwardD (derivative) | — | SEC | |
NeuBase Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Lantern Pharma Inc.Listing on record | AwardD (derivative) | — | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
NeuBase Therapeutics, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ELI LILLY & CoListing on record | Award | $66.7K | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Vyant Bio, Inc.Listing unverified | Award | — | SEC | |
Vyant Bio, Inc.Listing unverified | Award | — | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ELI LILLY & CoListing on record | Award | $160K | SEC | |
Vyant Bio, Inc.Listing unverified | Award | — | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ELI LILLY & CoListing on record | Award | $145K | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
ELI LILLY & CoListing on record | Award | $145K | SEC | |
Vyant Bio, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Vyant Bio, Inc.Listing unverified | Award | — | SEC |